Pro Nephro AKI (NGAL) is now FDA-Cleared READ MORE

Investor Contacts

Other Ways to Connect

To receive investor announcements, please subscribe below.

EU Investor Relations

Claus Thestrup, HC Andersen Capital

US Investor Relations

Ashley Robinson, LifeSci Advisors

BioPorto A/S Headquarters

Tuborg Havnevej 15
2900 Hellerup
Denmark

Contact Investor Relations

Name(Required)

First Last

Email(Required)

Phone

Country(Required)

States(Required)

Message(Required)

Name

This field is for validation purposes and should be left unchanged.